FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology and concerns treating lung cancer, particularly its non-small cell form. For this purpose, a radical surgery is followed by administering cytostatics according to the standard technique on the 1st, 3rd and 5th day of an adjuvant therapy. On the 2nd, 4th and 6th day, there are performed transfusions of autogenous blood incubated with ingaron 500000 IU per m2 of a patient's body surface, but no more than 1000000 IU per one injection. The incubation is carried out for 3 hours at a temperature of 37°C. Three courses are performed.
EFFECT: method provides higher clinical effectiveness in relieving side effects ensured by enhancing the anticancer and antiproliferative action of ingaron.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF INOPERABLE ASCTIC FORMS OF OVARIAN CANCER | 2016 |
|
RU2624509C1 |
METHOD FOR TREATING CEREBRAL METASTASES OF GENERALIZED SKIN MELANOMA | 2005 |
|
RU2286146C1 |
METHOD OF TREATING LUNG CANCER | 2011 |
|
RU2464992C1 |
METHOD OF LUNG CANCER TREATMENT | 2014 |
|
RU2554750C1 |
LUNG CANCER THERAPY | 2009 |
|
RU2406452C1 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438659C1 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438675C1 |
METHOD OF TREATING LUNG CANCER | 2010 |
|
RU2463062C2 |
Authors
Dates
2014-06-20—Published
2011-12-12—Filed